Proposed revised nomenclature for transfusion-related acute lung injury

Transfusion

Volumn 57, Issue 3, 2017, Pages 709-713

  Toy, Pearl ^a   Kleinman, Steven H ^c   Looney, Mark R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY MEDIATED REJECTION; BLOOD TRANSFUSION REACTION; DISEASE CLASSIFICATION; HUMAN; ISCHEMIA; MEDICAL TERMINOLOGY; MORBIDITY; NOTE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TRANSFUSED ACUTE RESPIRATORY DISTRESS SYNDROME; TRANSFUSION; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; VIGNETTE; ACUTE LUNG INJURY; BLOOD; CLASSIFICATION;

ACUTE LUNG INJURY; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TRANSFUSION REACTION;

EID: 85007275704     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13944     Document Type: Note

References (21)

1. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-6.
2. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774-89.
3. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757-67.
4. Toy P, Bacchetti P, Grimes B, et al. Recipient clinical risk factors predominate in possible transfusion-related acute lung injury. Transfusion 2015;55:947-52.
5. Kleinman SH, Triulzi DJ, Murphy EL, et al. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion 2011;51:2078-91.
6. Looney MR, Roubinian N, Gajic O, et al. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury. Crit Care Med 2014;42:1676-87.
7. Bux J. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011;100:122-8.
8. Peters AL, Vlaar AP. Redefining transfusion-related acute lung injury: don't throw the baby out with the bathwater. Transfusion 2016;56:2384-8.
9. Toy P, Kleinman SH, Looney MR. Reply to concerns regarding dropping the term “possible TRALI.” Transfusion 2016;56:2394-5.
10. Kor DJ, Kashyap R, Weiskopf RB, et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med 2012;185:842-50.
11. Feiner JR, Gropper MA, Toy P, et al. A clinical trial to detect subclinical transfusion-induced lung injury during surgery. Anesthesiology 2015;123:126-35.
12. Peters AL, van Hezel ME, Cortjens B, et al. Transfusion of 35-day stored RBCs in the presence of endotoxemia does not result in lung injury in humans. Crit Care Med 2016;44:e412-9.
13. Gajic O, Dabbagh O, Park PK, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011;183:462-70.
14. The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-33.
15. Rollins MD, Molofsky AB, Nambiar A, et al. Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit. Crit Care Med 2012;40:2488-91.
16. Warkentin TE, Greinacher A, Bux J. The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia. Transfusion 2015;55:1128-34.
17. Peters AL, Van Stein D, Vlaar AP. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention. Br J Haematol 2015;170:597-614.
18. Curtis BR, Roman AS, Sullivan MJ, et al. Two cases of maternal alloimmunization against human neutrophil alloantigen-4b, one causing severe alloimmune neonatal neutropenia. Transfusion 2016;56:101-6.
19. Bux J. Human neutrophil alloantigens. Vox Sang 2008;94:277-85.
20. Reil A, Keller-Stanislawski B, Günay S, et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008;95:313-7.
21. Peters AL, van Hezel ME, Juffermans NP, et al. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside. Blood Rev 2015;29:51-61.